2,3,7,8-tetrachlorodibenzo-p-dioxin augments the modulation of gene expression mediated by the thyroid hormone receptor

Toxicology and Applied Pharmacology

Volumn 194, Issue 3, 2004, Pages 201-210

  Yamada Okabe, Toshiko ^a   Aono, Takeshi ^a   Sakai, Haruya ^a   Kashima, Yuji ^a   Yamada Okabe, Hisafumi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

4 1BB; BMP6; Gene expression; TCDD; Thyroid hormone; Thyroid hormone receptor

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 4 HYDROXY 2',3',4',5,5' PENTACHLOROBIPHENYL; 4,4' ISOPROPYLIDENEDIPHENOL; BIPHENYL DERIVATIVE; BONE MORPHOGENETIC PROTEIN 6; CASPASE; CD137 ANTIGEN; LIOTHYRONINE; LUCIFERASE; MESSENGER RNA; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PROSTATE STEM CELL ANTIGEN; PROTEIN; PROTEIN FMFC; RANTES; RNA; THYROID HORMONE; THYROID HORMONE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; CELL ACTIVITY; CELL CULTURE; CONTROLLED STUDY; DNA MICROARRAY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETICS; HELA CELL; HORMONE ACTION; HUMAN; HUMAN CELL; METABOLISM; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 0842308023     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2003.09.010     Document Type: Article

References (45)

1. Alderson M.R., Smith C.A., Tough T.W., Davis-Smith T., Armitage R.J., Falk B., Roux E., Baker E., Sutherland G.R., Din W.S. Molecular and biological characterization of human 4-1BB and its ligand. Eur. J. Immunol. 24:1994;2219-2227.
2. Arch R.H., Thompson C.B. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor κB. Mol. Cell. Biol. 18:1998;558-565.
3. Ballock R.T., Zhou X., Mink L.M., Chen D.H.C., Mita B.C., Stewart M.C. Expression of cyclin-dependent kinase inhibitors in epiphyseal chondrocytes induction to terminally differentiate with thyroid hormone. Endocrinology. 141:2000;4552-4557.
4. Bergeron R.M., Thompson T.B., Leonard L.S., Pluta L., Gaido K.W. Estrogenicity of bisphenol A in a human endometrial carcinoma cell line. Mol. Cell. Endocrinol. 150:1999;179-187.
5. Chae K., McKinney J.D. Molecular complexes of thyroid hormone tyrosyl rings with aromatic donors. Possible relationship to receptor protein interactions. J. Med. Chem. 31:1988;357-362.
6. Cheek A.O., Kow K., Chen J., McLachlan J.A. Potential mechanisms of thyroid disruption in humans: interaction of organochlorine compounds with thyroid receptor, transthyretin, and thyroid binding globulin. Environ. Health Perspect. 107:1999;273-278.
7. De Felice M., Ovitt C., Biffali E., Rodriguez-Mallon A., Arra C., Anastassiadis K., Macchia P.E., Mattei M.-G., Mariano A., Scholer H., Macchia V., Di Lauro R. A mouse model for hereditary thyroid dysgenesis and cleft palate. Nat. Genet. 19:1998;395-398.
8. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
9. Feng X., Jiang Y., Maltzer P., Yen M.P. Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. Mol. Endocrinol. 14:2000;947-955.
10. Glass C.K. Some new twists in the regulation of gene expression by thyroid hormone and retinoic acid receptors. J. Endocrinol. 150:1996;349-357.
11. Gu Z., Thomas G., Yamashiro J., Shintaku I.P., Dorey F., Raitano A., Witte O.N., Said J.W., Loda M., Reiter R.E. Prostate stem cell antigen (PSCA) expression increases with high Gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene. 19:2000;1288-1296.
12. Hong L.Y., McKinney J.D., Luster M.I. Modulation of 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD)-mediated myelotoxicity by thyroid hormones. Biochem. Pharmacol. 36:1987;1361-1365.
13. Hornbeck P. Enzyme-linked immunosorbent assays. Coligan J.E., Kruisbeek A.M., Margulies D.H., Shevach E.M., Strober W. Current Protocols in Immunology. 1994;2.1.1-2.1.22 Wiley, USA.
14. Jaiswal A.K., Gonzalez F.J., Nebert D.W. Human dioxin-inducible cytochrome P1-450: complementary DNA and amino acid sequence. Science. 228:1985;80-83.
15. Jorns A., Tiedge M., Lenzen S. Throxine induces pancreatic beta-cell apoptosis in rats. Diabetologia. 45:2002;851-855.
16. Keith L.H. 2,3,7,8-TCDD. Environmental Endocrine Disruptors; A Handbook of Property Data. 1997;1101-1107 Wiley, New York, NY.
17. Lamb J.C. IV, Harris M.W., McKinney J.D., Birnbaum L.S. Effects of thyroid hormones on the induction of cleft palate by 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD) in C57BL/6N mice. Toxicol. Appl. Pharmacol. 84:1986;115-124.
18. Lazar M.A. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr. Rev. 14:1993;184-193.
19. Legler J., Zeinstra L.M., Schuitemaker F., Lanser P.H., Bogerd J., Brouwer A., Vethaak A.D., DeVoogt P., Murk A.J., Van der Burg B. Comparison of in vivo and in vitro reporter gene assays for short-term screening of estrogenic activity. Environ. Sci. Technol. 15:2002;4410-4415.
20. Leslie K.K., Watanabe S., Lei K.-J., Chou D., Plouzek C.A., Deng H.-C., Torres J., Chou J.Y. Linkage of two human pregnancy-specific beta 1-glycoprotein genes: one is associated with hydatidiform mole. Proc. Natl. Acad. Sci. U.S.A. 87:1990;5822-5826.
21. Lin P.S., Lin C.M. Phthalates suppress the calcium signaling of nicotinic acetylcholine receptors in bovine adrenal chromaffin cells. Toxicol. Appl. Pharmacol. 183:2002;92.
22. Maehara N., Matumoto K., Kuba K., Mizumoto K., Tanaka M., Nakamura T. NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cell. Br. J. Cancer. 84:2001;864-873.
23. Osborne R., Dold K.M., Greenlee W.F. Evidence that 2,3,7,8- tetrachlorodibenzo-p-dioxin and thyroid hormones act through different mechanisms in human keratinocytes. Toxicol. Appl. Pharmacol. 90:1987;522-531.
24. Portier C.J. Endocrine dismodulation and cancer. Neuroendocrinol. Lett. 23(Suppl. 2):2002;43-47.
25. Reiter R.E., Gu Z., Watabe T., Thomas G., Szigeti K., Davis E., Wahl M., Nisitani S., Yamashiro J., LeBeau M.M., Loda M., Witte O.N. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 95:1998;1735-1740.
26. Rickard D.J., Hofbauer L.C., Bonde S.K., Gori F., Spelsberg T.C., Rigg B.L. Bone morphogenetic protein-6 production in human osteoblastic cell lines. J. Clin. Invest. 101:1998;413-422.
27. Rohan P.J., Davis P., Moskaluk C.A., Kearns M., Krutzsch H., Siebenlist U., Kelly K. PAC-1: a mitogen-induced nuclear protein tyrosine phosphatase. Science. 259:1993;1763-1766.
28. Rolland R.M. A review of chemically-induced alteration in thyroid and vitamin A status from field studies of wildlife and fish. J. Wildl. Dis. 36:2000;615-635.
29. Rowlands J.C., Gustafsson J.A. Aryl hydrocarbon receptor-mediated signal transduction. Crit. Rev. Toxicol. 27:1997;109-134.
30. Rozman K., Rozman T., Greim H.&& Effect of thyroidectomy and thyroxine on 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induced toxicity. Toxicol. Appl. Pharmacol. 72:1984;372-376.
31. Safe S., Wang F., Porter W., Duan R., McDougal A. Ah receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms. Toxicol. Lett. 102-103:1998;343-347.
32. Sap J., Munoz A., Damm K., Goldberg Y., Ghysdael J., Lentz A., Beng H., Vennstrom B. The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature. 324:1986;635-640.
33. Sewall C.H., Flagler N., Vanden Heuvel J.O., Clark G.C., Tritscher A.M., Maronpot R.M., Lucier G.W. Alteration in thyroid function in female Sprague-Dawley rats following chronic treatment with 2,3,7,8-tetrachlorodibenzo- p-dioxin. Toxicol. Appl. Pharmacol. 132:1995;237-244.
34. Sharma D., Fondell J.D. Temporal formation of distinct thyroid hormone receptor coactivator complexes in HeLa cells. Mol. Endocrinol. 14:2000;2001-2009.
35. Shi Y.-B., Ishizuya-Oka A. Thyroid hormone regulation of apoptotic tissue remodeling: implications from molecular analysis of amphibian metamorphosis. Prog. Nucleic Acid Res. Mol. Biol. 65:2001;53-100.
36. Shih A., Lin H.Y., Davis F.B., Davis P.J. Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase. Biochemistry. 40:2001;2870-2878.
37. Spangenberg D.B. Thyroxine induced metamorphosis in Aurelia. J. Exp. Zool. 178:1971;183-194.
38. Tatarinov Y.S., Falaleeva D.M., Kalashinikov V.V. Human pregnancy-specific beta-1-globulin and its relation to chorioepithelioma. Int. J. Cancer. 17:1976;626-632.
39. Vassart G., Dumont J.E., Refetoff S. Thyroid disorders. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. 1995;2883-2928 McGraw-Hill Inc., Health Professions Division, New York.
40. Weber L.W., Lebofsky M., Stahl B.U., Smith S., Rozman K.K. Correlation between toxicity and effects on intermediary metabolism in 2,3,7,8- tetrachlorodibenzo-p-dioxin-treated male C57BL/6J and DBA/2J mice. Toxicol. Appl. Pharmacol. 131:1995;155-162.
41. Weinberger C., Thompson C.C., Ong E.S., Lebo R., Gruol D.J., Evans R.M. The c-erb-A gene encodes a thyroid hormone receptor. Nature. 324:1986;641-646.
42. Weitzel J.M., Radtke C., Steitz H.J. Two thyroid hormone-mediated gene expression patterns in vivo identified by cDNA expression arrays in rat. Nucleic Acids Res. 29:2001;5148-5155.
43. Yamada-Okabe T., Satoh Y., Yamada-Okabe H. Thyroid hormone induces the expression of 4-1BB and activates caspases in a thyroid hormone receptor dependent manner. Eur. J. Biochem. 270:2003;3064-3073.
44. Yen P.M. Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 81:2001;1097-1142.
45. Yin Y., Liu Y.-X., Jin Y.J., Hall E.J., Barrett J.C. PAC1 phosphatase is a transcription target of p53 in signaling apoptosis and growth suppression. Nature. 422:2003;527-531.